Bill Detail
S. 1954
Congress: 119
Title
Biosimilar Red Tape Elimination Act
Summary
No summary published on Congress.gov yet — common for recently introduced bills.
Sponsor
Sen. Mike Lee [R-UT]
Status
Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
Status as of Jun 29, 11:21 AM · synced 9h ago
Introduced
2025-06-04
Data source mode: cache
Bill Engagement
Biosimilar Red Tape Elimination Act
Sponsor
Sen. Mike Lee [R-UT]R
Status
Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
Cosponsors
3D · 2R
Bipartisan
LDA engagement
7 orgs · 10 filings
Top: Pharmaceutical Research and Manufactur…
Introduced
2025-06-04
Lobbyists on the case
7 orgs · 71 lobbyists · 10 filings mention S. 1954 (Biosimilar Red Tape Elimination Act) in LDA disclosures.
Top orgs filing
- Pharmaceutical Research and Manufacturers of America4 filings · 26 lobs
- Johnson & Johnson Services, Inc.1 filing · 16 lobs
- America's Health Insurance Plans, Inc. (AHIP)1 filing · 12 lobs
- Blue Cross and Blue Shield Association1 filing · 6 lobs
- Fierce Government Relations1 filing · 6 lobs
- American Society of Health-system Pharmacists1 filing · 3 lobs
Lobbyists on this bill
- Teresa Bill2026 Q1
- Elenora Connors2026 Q1
- Catherine Douglas2026 Q1
- Bart Forsyth2026 Q1
- Jake Freed2026 Q1Pharmaceutical Research and Manufacturers of America · Cong. Affairs Specialist - FDA; Leg. Asst., Leg. Aide/Press Asst., Staff Asst., District Field Re…
- Kelly Goldberg2026 Q1
- Judith Haron2026 Q1
- Lauren Jee2026 Q1
+ 63 more